Frontotemporal Dementia (FTD) drugs in development, 2024

GlobalData tracks 119 drugs in development for Frontotemporal Dementia (FTD) by 92 companies/universities/institutes. The top development phase for Frontotemporal Dementia (FTD) is preclinical, with 66 drugs in that stage.

Advancement of potential gene therapy could offer new hope for children with Batten disease

A new study shows that delivery of gene therapy to correct the gene mutations that cause CLN2 disease, or Batten disease, directly into the cerebrospinal

September 28, 2023

Stryker in ‘sprint back to 2019’ as procedures grow and supply chain, staffing pressures improve

By the numbers Q3 sales: $4.91 billion 9.6% year-over-year increase Orthopedics & Spine sales: $2.05 billion 8.4% year-over-year increase MedSurg & Neurotechnology sales: $2.86 billion 11% year-over-year

November 3, 2023

Astrocytes found to play pivotal role in epileptic neuronal hyperactivity

Epilepsy, where patients suffer from unexpected seizures, affects roughly 1% of the population. These seizures often involve repetitive and excessive neuronal firing, with the trigger

April 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.